Mycobacterium avium lysate induces matrix metalloproteinase-1 in intestinal tissue and peripheral blood: Observations from selected hospital based Zambian adults

[1]  C. Michelo,et al.  Diagnostic yield of nontuberculous mycobacteria in patients booked for endoscopy at the University Teaching Hospital, Lusaka , 2017, BMC Research Notes.

[2]  S. Vermeire,et al.  The molecular biology of matrix metalloproteinases and tissue inhibitors of metalloproteinases in inflammatory bowel diseases , 2016, Critical reviews in biochemistry and molecular biology.

[3]  B. Amadi,et al.  Endomicroscopic and Transcriptomic Analysis of Impaired Barrier Function and Malabsorption in Environmental Enteropathy , 2016, PLoS neglected tropical diseases.

[4]  Rashidul Haque,et al.  Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh , 2015, EBioMedicine.

[5]  J. Gilmer,et al.  Matrix Metalloproteinases in Inflammatory Bowel Disease: An Update , 2015, Mediators of inflammation.

[6]  Ta-Chiang Liu,et al.  IL-6 Stimulates Intestinal Epithelial Proliferation and Repair after Injury , 2014, PloS one.

[7]  Simon A. Jones,et al.  Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production , 2014, Nature Medicine.

[8]  T. Macdonald,et al.  Proteases and small intestinal barrier function in health and disease , 2014, Current opinion in gastroenterology.

[9]  Poonam Kothari,et al.  IL-6–Mediated Induction of Matrix Metalloproteinase-9 Is Modulated by JAK-Dependent IL-10 Expression in Macrophages , 2014, The Journal of Immunology.

[10]  C. Garlanda,et al.  The interleukin-1 family: back to the future. , 2013, Immunity.

[11]  P. Lee,et al.  Is a Cutoff of 10% Appropriate for the Change-in-Estimate Criterion of Confounder Identification? , 2013, Journal of epidemiology.

[12]  D. Rodgers,et al.  Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. , 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[13]  G. Corazza,et al.  Proteases and the gut barrier , 2013, Cell and Tissue Research.

[14]  Jos W. M. van der Meer,et al.  Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases , 2012, Nature Reviews Drug Discovery.

[15]  S. Mazmanian,et al.  Intestinal Microbes in Inflammatory Bowel Diseases , 2012 .

[16]  E. Roeb,et al.  Induction of matrix metalloproteinases and TLR2 and 6 in murine colon after oral exposure to Mycobacterium avium subsp. paratuberculosis. , 2012, Microbes and infection.

[17]  W. Petri,et al.  Environmental enteropathy: critical implications of a poorly understood condition. , 2012, Trends in molecular medicine.

[18]  A. Prendergast,et al.  Enteropathies in the developing world: neglected effects on global health. , 2012, The American journal of tropical medicine and hygiene.

[19]  Dirk Haller,et al.  Bacterial proteases in IBD and IBS , 2011, Gut.

[20]  T. Shiomi,et al.  MMP-1 drives immunopathology in human tuberculosis and transgenic mice. , 2011, The Journal of clinical investigation.

[21]  M. Bajaj‐Elliott,et al.  Differential effects of Staphylococcal enterotoxin B‐mediated immune activation on intestinal defensins , 2009, Clinical and experimental immunology.

[22]  T. Macdonald,et al.  The role of matrix metalloproteinases in stromal/epithelial interactions in the gut. , 2007, Physiology.

[23]  P. Garg,et al.  Matrix metalloproteinases in inflammatory bowel disease: Boon or a bane? , 2007, Inflammatory bowel diseases.

[24]  Angelo A. Izzo,et al.  Role for Matrix Metalloproteinase 9 in Granuloma Formation during Pulmonary Mycobacterium tuberculosis Infection , 2006, Infection and Immunity.

[25]  C. Feighery,et al.  Increased Protein Expression of Matrix Metalloproteinases -1, -3, and -9 and TIMP-1 in Patients with Gluten-Sensitive Enteropathy , 2006, Digestive Diseases and Sciences.

[26]  Yuji Naito,et al.  Role of matrix metalloproteinases in inflammatory bowel disease. , 2005, Molecular aspects of medicine.

[27]  D. Schuppan,et al.  Matrix metalloproteinase pattern in celiac duodenal mucosa , 2005, Laboratory Investigation.

[28]  J. Mwansa,et al.  Responses of small intestinal architecture and function over time to environmental factors in a tropical population. , 2004, The American journal of tropical medicine and hygiene.

[29]  M. Bajaj‐Elliott,et al.  Intestinal defensin gene expression in human populations. , 2003, Molecular immunology.

[30]  D. Merlin,et al.  IL-6 Induces NF-κB Activation in the Intestinal Epithelia 1 , 2003, The Journal of Immunology.

[31]  J. Falkinham.  Nontuberculous mycobacteria in the environment. , 2002, Clinics in chest medicine.

[32]  I. Zulu,et al.  Tropical enteropathy: a T-cell-mediated crypt hyperplastic enteropathy , 2001, European journal of gastroenterology & hepatology.

[33]  G. Bancroft,et al.  Production of Matrix Metalloproteinases in Response to Mycobacterial Infection , 2001, Infection and Immunity.

[34]  C. Gerson,et al.  Subclinical malabsorption in developing countries. , 1972, The American journal of clinical nutrition.

[35]  THE JOURNAL OF CLINICAL NUTRITION , 1953, The Ulster Medical Journal.

[36]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.